Thoughts on God’s word (letter) – York Daily Record
By Dr. Matthew Watson
Thoughts on God's word (letter) York Daily Record The essential meaning of this revelation is contradicted by Darwin's hypothesis, which is itself lamentably deficient in evidence, and now contradicted by molecular genetics. Moreover, the symbolism of the image of God in the sexual union of man and ... |
Uncategorized
Comments Off on Thoughts on God’s word (letter) – York Daily Record |
July 28th, 2013
Wilkes University Professor William Terzaghi of Kingston, Pa., Lectures in China – Wilkes University
By Dr. Matthew Watson
Wilkes University Professor William Terzaghi of Kingston, Pa., Lectures in China Wilkes University Terzaghi flew into Beijing and delivered the first of four lectures on the topic “Studying the Molecular Basis of Hybrid Vigor” and one workshop at the Peking-Yale Joint Center for Plant Molecular Genetics and Agro-Biotechnology, a division of Peking ... |
Uncategorized
Comments Off on Wilkes University Professor William Terzaghi of Kingston, Pa., Lectures in China – Wilkes University |
July 28th, 2013
California Stem Cell Official Duane Roth in Improving Condition
By Dr. Matthew Watson
California stem cell agency, is improving after he was hospitalized
for treatment of a serious brain injury sustained in a bicycle accident Sunday in
the mountains east of San Diego.
Roth's brother, Ted, said yesterday,
“Were certainly moving in the
right direction. We're now looking at the recovery phase.”
has passed through the most critical period following surgery at the
UC San Diego hospital.
Diego technology organization, Connect, is in serious condition in a
medically induced coma.
stem cell agency yesterday took special note of Roth at its meeting and sent its best wishes to him and his family.
Source:Stem Cell Therapy
Comments Off on California Stem Cell Official Duane Roth in Improving Condition |
July 28th, 2013
Another $23 Million to Recruit Star Stem Cell Scientists to California
By Dr. Matthew Watson
stem cell research stars to the Golden State was expanded today by
another $23 million.
approved the funds on a 14-4-1 vote. CIRM directors Jeff Sheehy and
Francisco Prieto were among those opposing the move. Prieto declared,
“We are coming up against finite resources. We have better ways to spend
our money."
Sheehy said that CIRM is contributing to inflation in stem cell science with its lucrative recruitment grants.
institutions that have not already benefited from one of the earlier
grants in the program. Up to four awards are expected to be made.
said,
“A number of California institutions
have not yet been able to secure a confirmed Research Leadership
award but would benefit greatly from the recruitment of emerging or
established leaders in stem cell biology. Participation in the CIRM
program could bring additional, exceptional researchers to
California, strengthen and synergize with other efforts to build up
local sustained research communities in stem cell biology and
medicine and provide ongoing leadership at the cutting edge of
California regenerative medicine.”
involved with the winning researchers have representatives on the
governing board of the stem cell agency. They are not allowed, however, to vote
on grants to their institutions or researchers -- only on proposals such as today's $23 expansion.
final approval scheduled for next May. The program is not open to
businesses.
Source:Stem Cell Therapy
Comments Off on Another $23 Million to Recruit Star Stem Cell Scientists to California |
July 28th, 2013
California Stem Cell Agency Launches $70 Million Alpha Stem Cell Clinic Project
By Dr. Matthew Watson
The California stem cell agency today approved
a $70 million plan to create a network of “Alpha” stem cell
clinics that is aimed at making the Golden State one of the leading
purveyors and developers of stem cell therapies in the world.
Institute for Regenerative Medicine (CIRM)adopted the plan on a 19-1 vote. The negative vote came from Joan Samuelson, who questioned
whether the plan was premature and whether existing scientific research justified development of the clinics.
former head of a Hollywood studio, said the proposal is “one of the
most exciting proposals that we have ever had in front of us.” She
said it was the “beginning of this dream coming true.”
CIRM President Alan Trounson has been promoting for two years, the
agency will finance five stem cell clinics at established
institutions in California with grants of up to $11 million. Another
$15 million will be allotted for a stem cell information and
coordination center. Major matching contributions will be expected
from award winners over the five-year terms of the grants.
clinical trials and patients from the around the world and creating a
central bank of knowledge, know-how and regulatory expertise. It
will also guide efforts to build profits into stem cell therapies
and to develop strategies to attract investors and philanthropists.
(For more information on the plan, see here, here, here, here and
here.)
“These clinics have the potential to
revolutionize how we deliver stem cell therapies to patients. Stem
cell therapies are a completely new way of treating diseases and
disorders so we need a completely new way of delivering those in a
safe and effective manner. These clinics will help us do just that
and the clinical trials carried out in this network will fulfill the
agency’s promise of bringing new therapies to patients who need
them.”
reported that the Alpha clinics would be the first-ever “clinical
trials network focused around a broad therapeutic platform.”
comment on the plan other than the remarks by Samuelson. . However,
not everyone sees a need for it. Mahendra Rao, director of the Center
for Regenerative Medicine at the National Institutes of
Health(NIH) , says its surveys of researchers have not shown a demand
for such centers. In May, a researcher at institution that likely
would be an applicant filed a blistering, anonymous comment on the
California Stem Cell Report, describing it as a "boondoggle" and "irresponsible." The scientist said,
“Another boondoggle for some medical
schools but made to order for private operators like for-profit
cancer, dialysis, and laser eye specialty clinics that do one
procedure. I can see each of the medical schools gifted with
one as they each were gifted with about 25 million dollars for stem
cell institute buildings.”
“The NIH at various times has tried
to organize clinical trials groups with infrastructure, like quick
reaction forces, ready to gear up for a new trial at the drop of a
hat. They mainly did nothing but suck money, kept staff employed,
because there are generally few drugs ready for early human trials
and each treatment that is brought along requires a unique contract,
ethics reviews, and different facilities, equipment and staff than
planned for. The latest incarnation are CTSAs or CTSIs,
clinical and translational science centers funded by the federal NIH
that most if not all California medical schools already have.”
go out in October and approval of funding coming one year from now. Here is the link to today's CIRM press release on the plan.
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/EBbBzLL9dQQ/california-stem-cell-launches-70.html
Stem Cell Therapy
Comments Off on California Stem Cell Agency Launches $70 Million Alpha Stem Cell Clinic Project |
July 28th, 2013
Coming Up: Live Coverage of Today’s California Stem Cell Meeting
By Dr. Matthew Watson
provide live, wall-to-wall coverage of today's meeting of the
governing board of the $3 billion California stem cell agency.
million proposal aimed at creating a string of Alpha stem cell clinics in
California that would serve as a foundation for the state's stem cell
business. Also on tap are other proposed grant programs, including a
$23 million expansion of a researcher recruitment effort and a $35 million round aimed at removing roadblocks to turning research into
cures.
throughout the day based on the Internet audiocast of the proceedings.
on the meeting via the Internet. Instructions can be found on the agenda.
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/Vi8IGlL2TzY/coming-up-live-coverage-of-todays.html
Stem Cell Therapy
Comments Off on Coming Up: Live Coverage of Today’s California Stem Cell Meeting |
July 28th, 2013
Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions
By Dr. Matthew Watson
agency today balked at approving a plan to ease restrictions on
using stem cell lines derived from women who were paid for their
eggs.
taken up tomorrow by the governing board of the $3 billion agency,
but the board's standards working group delayed action.
McCormack, a spokesman for the agency, said in an email,
“It was felt that more discussion
was needed before moving to a vote so another meeting is going to be
scheduled.”
approved regulations that banned the use of CIRM funds for stem cells
lines derived using compensation. That rule would be modified under
today's plan, which would permit the CIRM governing board to approve
the use of such lines following a staff study evaluating scientific and ethical issues.
Their use would be allowed if the lines would “advance CIRM's
mission.”
The delay came after four
organizations, including the Center for Genetics and Society in
Berkeley, argued that the plan is vague and did not adequately
address safety issues.
said that the plan does not appear to have met “numerous concerns”
raised in 2009 in a document co-authored by the CIRM staff. Those
concerns include long-term risk and ethical issues.
that the agency governing board
“...will decide whether to approve a
grantee’s request to use a stem cell line created with paid-for
eggs on the basis of whether doing so 'will advance CIRM’s
mission.' This criterion is much too vague, and doesn’t include
consideration of the health or welfare of the women who undergo egg
retrieval. Protecting the well-being of women providing eggs is not
even mentioned (though perhaps it could be considered as an element
of the fifth of five 'factors to be considered by the ICOC(the agency
board),' 'whether the donation…was consistent with `best practices’
at the time of donation').”
The standards group also heard from a
UCLA researcher who argued on behalf of the change. Kathrin Plath
said she and her colleagues wanted to use a paid-for stem cell line
from the Oregon experiment that cloned human stem cells.
the four organizations.
Source:Stem Cell Therapy
Comments Off on Stem Cell Lines and Paid-for Eggs: Stem Cell Agency Delays Action on Easing Restrictions |
July 28th, 2013
$70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention
By Dr. Matthew Watson
chain of “Alpha” stem cell clinics today received its first major
attention from the mainstream media.
circulation newspaper, appearing this morning on the home page of the
website of Los Angeles Times.
around the state and a coordination/information center under a
concept that comes before the governing board of the state's $3
billion stem cell agency at its meeting tomorrow in Burlingame, Ca. Funds could be
awarded as early as a year from now. (For more information, see here
and here.)
DeWitt, special projects officer for CIRM, as the stem cell agency is known, and Maria Millan, a CIRM
medical officer. Brown wrote,
“Clinics to conduct trials of stem
cell therapies have different needs than clinics designed to deliver
conventional therapies, DeWitt and Millan said. They need special
facilities for handling the cells safely, as well as imaging
equipment to track the cells once they're delivered into a patient’s
body. Some of this infrastructure already exists, but other
parts of it still need to be perfected. Establishing clinics to
house multiple trials might create the critical mass needed to get
the infrastructure in place, they said....
"Additionally, they said, CIRM
hopes that such collaboration would encourage stem cell companies to
share information -- speeding their own work and also helping out
policymakers and insurers who are trying to figure out how they'll
pay for stem cell therapies in the future.”
California Stem Cell Report as saying last week,
“The Alpha clinics
are aimed at creation of a sturdy foundation for the stem cell
industry in California, capitalizing on the burgeoning, international
lure of stem cell treatments.”
clinics at major, established institutions around the state. It is
possible that two could be located in the Los Angeles area at
institutions such as UCLA, USC, Cedars-Sinai or the City of Hope, all
of which have representatives on the stem cell agency's governing
board. Other likely locations are in the San Francisco Bay area and
San Diego, again at facilities such as Stanford, UC San Francisco and
UC San Diego that have representation on the agency board.
including businesses, will be subject to closed-door. peer review
prior to final action by the full governing board.
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/s_-mm4nTU_0/70-million-alpha-stem-cell-clinic.html
Stem Cell Therapy
Comments Off on $70 Million Alpha Stem Cell Clinic Project Garners Mainstream Media Attention |
July 28th, 2013
UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers
By Dr. Matthew Watson
support of a proposal to allow use of California stem cell agency
funds to purchase stem cell lines derived from eggs provided by women
who have been paid for the service.
experiment by Shoukhrat Mitalipov in which human stem cells were cloned. Currently agency funds cannot be used for that purpose as
a result of regulations that are the extension of a state law that
bars use of agency funds for payment for eggs.
then go before the full board tomorrow.
“In my lab, we are ... interested in
understanding what happens to the somatically silenced X chromosome
when differentiated cells are reprogrammed by SCNT. The key question
is: are these SCNT-ESCs more similar to iPSCs or
fertilization-derived ESCs with respect to the epigenetic state of
the X chromosome. Furthermore, it has been shown in mouse
reprogramming that the active X chromosome becomes deregulated during
SCNT-based reprogramming, and we would like to address this problem
in the human system as well.
“We believe that the comparison of
the epigenetic states between fertilization-derived ESCs, SCNT-ESCs
and human iPSCs is important for a better characterization of these
cells and understanding of their epigenetic nature.”
Source:Stem Cell Therapy
Comments Off on UCLA Researcher Calls for Easing of Restrictions on Stem Cell Lines Derived from Eggs From Paid Providers |
July 28th, 2013
‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post
By Dr. Matthew Watson
'Frankenstein's Cat' poses ethical questions about biotechnology South China Morning Post Here's a cheery fact: between acts of war and more diabetes, the number of human amputees is expected to grow around 40 percent by 2020. This I learned from Frankenstein's Cat: Cuddling Up to Biotech's Brave New Beasts by Emily Anthes, a book I picked ... |
Uncategorized
Comments Off on ‘Frankenstein’s Cat’ poses ethical questions about biotechnology – South China Morning Post |
July 27th, 2013
FAQ4 A Scientific Basis for Stem Cell Therapy – Video
By Dr. Matthew Watson
FAQ4 A Scientific Basis for Stem Cell Therapy
http://youtu.be/uf_toA9Nzuo With all the hype online and in the media today, it is easy to believe that Stem Cell therapy is ALSO #39;hype #39;, but it actually eme...
By: Kerry Dean
Go here to read the rest:
FAQ4 A Scientific Basis for Stem Cell Therapy - Video
Uncategorized
Comments Off on FAQ4 A Scientific Basis for Stem Cell Therapy – Video |
July 26th, 2013
Stem Cell Therapy Used as Dog Arthritis Treatment – Video
By Dr. Matthew Watson
Stem Cell Therapy Used as Dog Arthritis Treatment
We have dedicated our careers to helping dogs live to the fullest extent possible. For more information please visit one of our articles below: Dog Arthritis...
By: Duncan Bulow
See the original post:
Stem Cell Therapy Used as Dog Arthritis Treatment - Video
Uncategorized
Comments Off on Stem Cell Therapy Used as Dog Arthritis Treatment – Video |
July 22nd, 2013
The Taste of Tomorrow: Genetic Engineering – The Daily Progress
By Dr. Matthew Watson
The Taste of Tomorrow: Genetic Engineering The Daily Progress Mr. Schonwald spent a considerable amount of time researching how genetic engineering might impact the salad bar of 2035. He explained, “When I started this project, I had a healthy suspicion of [genetically modified organisms]. I thought the idea of ... |
Uncategorized
Comments Off on The Taste of Tomorrow: Genetic Engineering – The Daily Progress |
July 21st, 2013
Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes
By Dr. Matthew Watson
Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized Forbes Investors considering a purchase of Puma Biotechnology Puma Biotechnology, Inc. (NYSE: PBYI) shares, but cautious about paying the going market price of $53.61/share, might benefit from considering selling puts among the alternative strategies at their ... |
Uncategorized
Comments Off on Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes |
July 21st, 2013
Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes
By Dr. Matthew Watson
Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For ... Forbes That's been the reality for years at the otherwise respectable environmental news site Grist on the issue of agricultural biotechnology. This is why the current series by food writer Nathaniel Johnson reassessing Grist's own reporting on crop ... |
Uncategorized
Comments Off on Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes |
July 21st, 2013
The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog)
By Dr. Matthew Watson
The top biotechnology companies in the Puget Sound area (slide show) Puget Sound Business Journal (Seattle) (blog) The region's top biotechnology companies are extremely secretive about their revenues. That's one conclusion that can be drawn from the Puget Sound Business Journal's list of the top biotech firms in the area. Eleven of the top 25 companies would not ... |
Uncategorized
Comments Off on The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog) |
July 21st, 2013
The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration)
By Dr. Matthew Watson
The real impact for healthcare and biotechnology of the Supreme Court's ... Lexology (registration) On June 13, 2013, the Supreme Court issued a decision supposedly resolving the patentability of DNA in Association for Molecular Pathology v. Myriad Genetics. Immediately, all parties on both sides of the case declared victory. The American Civil ... |
Uncategorized
Comments Off on The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration) |
July 21st, 2013
Biotechnology – Revolutions with Jon Faine – ABC Local
By Dr. Matthew Watson
 ABC Local | Biotechnology - Revolutions with Jon Faine ABC Local This week Revolutions looks at the new possibilities opened up by biotechnology and talks to listeners about the procedures they've had, procedures that would have been thought impossible just a few decades ago. Joining Jon Faine for the discussion is ... |
Uncategorized
Comments Off on Biotechnology – Revolutions with Jon Faine – ABC Local |
July 21st, 2013
Biotechnology: Monsanto drops new European GM food plans – Presseurop (English)
By Dr. Matthew Watson
 Los Angeles Times | Biotechnology: Monsanto drops new European GM food plans Presseurop (English) United States biotech giant Monsanto is ending all but one project to grow GM foods in Europe, reports German daily Die Welt. The firm announced on July 17 that it is withdrawing all permits requested to the European Commission to grow genetically ... In Perspective: Anti-GM vitriol risesagprofessional.com Monsanto drops GM crop plan in EUBBC News Millions Against Monsanto: On the Road to VictoryTruth-Out The Southern Times -Malaysia Sun all 82 news articles » |
Uncategorized
Comments Off on Biotechnology: Monsanto drops new European GM food plans – Presseurop (English) |
July 21st, 2013
LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The … – PR Web (press release)
By Dr. Matthew Watson
LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The ... PR Web (press release) Dr. Santani holds specialty board certifications in Clinical Molecular Genetics and Clinical Cytogenetics. Her primary focus is on new test development and adoption of next generation sequencing technologies for diagnostic testing. Dr. Santani has ... |
Uncategorized
Comments Off on LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The … – PR Web (press release) |
July 21st, 2013